🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We are excited to welcome Julie Smeyers, PhD from Paris to our group at the Weill!

Highlighting an excellent review article on C9ORF72 biology and models of C9-ALS/FTD by Julie Smeyers. C9ORF72: What It Is, What It Does, and Why It Matters frontiersin.org/article/10.338…

Very happy to be part of this team !

We are so excited to share the first publication from our lab! An introduction to an excellent review article by Ito et al. recently out in Brain. Running up that pill for amyotrophic lateral sclerosis academic.oup.com/brain/advance-…

My UCSF postdoc slam video is out! 1st prize, 2 killers, 3 minutes. #FTD Graduate Education and Postdoctoral Affairs

We’re hiring a postdoc! Please reach out or share if you know someone interested in studying neurobiology and neurodegeneration as part of an outstanding research environment at Mission Bay. Institute for Neurodegenerative Diseases #dementia #ALS opportunities.ucsf.edu/content/postdo…

In this study, we observed that a C9ORF72-ALS/FTD dipeptide repeat protein perturbs the phosphorylation of RNA binding proteins and STMN2 expression, and found that SRSF7 sustains STMN2 levels in induced neurons. Congrats to Julie Smeyers and Karen! #ALS actaneurocomms.biomedcentral.com/articles/10.11…